Journal Logo

June 2020 - Volume 4 - Issue 3
pp: e356-e356

Upfront Daratumumab With Lenalidomide and Dexamethasone for POEMS Syndrome

Gavriatopoulou, Maria; Ntanasis-Stathopoulos, Ioannis; Fotiou, Despina; More

HemaSphere. 4(3):e381, June 2020.

Clinical Characteristics and Outcome of West Nile Virus Infection in Patients with Lymphoid Neoplasms: An Italian Multicentre Study

Visentin, Andrea; Nasillo, Vincenzo; Marchetti, Monia; More

HemaSphere. 4(3):e395, June 2020.



Longitudinal Cytokine Profiling Identifies GRO-α and EGF as Potential Biomarkers of Disease Progression in Essential Thrombocythemia

Øbro, Nina F.; Grinfeld, Jacob; Belmonte, Miriam; More

HemaSphere. 4(3):e371, June 2020.

Response and Survival Outcomes to Ibrutinib Monotherapy for Patients With Waldenström Macroglobulinemia on and off Clinical Trials

Castillo, Jorge J.; Gustine, Joshua N.; Meid, Kirsten; More

HemaSphere. 4(3):e363, June 2020.

Results of an Early Access Treatment Protocol of Daratumumab Monotherapy in Spanish Patients With Relapsed or Refractory Multiple Myeloma

Alegre, Adrián; de la Rubia, Javier; Sureda Balari, Anna; More

HemaSphere. 4(3):e380, June 2020.

A Study of Safety and Efficacy of Nivolumab and Bendamustine (NB) in Patients With Relapsed/Refractory Hodgkin Lymphoma After Nivolumab Monotherapy Failure

Lepik, Kirill V.; Mikhailova, Natalia B.; Kondakova, Elena V.; More

HemaSphere. 4(3):e401, June 2020.

Final Results of a Phase I/II Trial of the Combination Bendamustine and Rituximab With Temsirolimus (BeRT) in Relapsed Mantle Cell Lymphoma and Follicular Lymphoma

Hess, Georg; Wagner, Karola; Keller, Ulrich; More

HemaSphere. 4(3):e398, June 2020.





Congenital and Acquired Chronic Neutropenias: Challenges, Perspectives and Implementation of the EuNet-INNOCHRON Action

Papadaki, Helen A.; Mavroudi, Irene; Almeida, Antonio; More

HemaSphere. 4(3):e406, June 2020.